Graham Capital Management’s Wave Life Sciences WVE Stock Holding History

Graham Capital Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125K	Buy	+21,491	New	+$142K	﹤0.01%	1127
2025 Q4	–	Sell	-43,946	Closed	-$322K	–	1621
2025 Q3	$322K	Buy	+43,946	New	+$356K	0.01%	827
2024 Q4	–	Sell	-20,950	Closed	-$172K	–	1510
2024 Q3	$172K	Buy	+20,950	New	+$125K	﹤0.01%	949
2024 Q2	–	Sell	-34,199	Closed	-$211K	–	1409
2024 Q1	$211K	Buy	34,199 +16,907	+98%	+$84.7K	﹤0.01%	883
2023 Q4	$87.3K	Buy	+17,292	New	+$92.4K	﹤0.01%	914

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Graham Capital Management's WVE Position: Q2 2026 in Review

Graham Capital Management opened a new position in Wave Life Sciences (WVE) in Q2 2026: 21,491 shares worth $125K. The stake represents ﹤0.01% of the portfolio and ranks #1127 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in WVE as recently as Q3 2025.

Graham Capital Management first reported a position in WVE in Q4 2023 and has held it in 5 quarters since. The position peaked at $322K in Q3 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Graham Capital Management held 21,491 shares of Wave Life Sciences worth $125K as of Q2 2026.
Wave Life Sciences was a new Graham Capital Management position in Q2 2026.
Wave Life Sciences made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1127 holding.
Graham Capital Management first reported a position in Wave Life Sciences in Q4 2023 and has held it in 5 quarters since.
Graham Capital Management's Wave Life Sciences position peaked at $322K in Q3 2025.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.